Skip to content
ppharmaranks
Menu

Best treatments for cytomegalovirus retinitis

3 products may treat cytomegalovirus retinitis, spanning FDA drug classes such as cytomegalovirus nucleoside analog dna polymerase inhibitor, nucleoside analog antiviral. The current highest-rated option is valganciclovir hydrochloride. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 3 drugs we list for cytomegalovirus retinitis, 2 are available as lower-cost generics, spanning classes such as cytomegalovirus nucleoside analog dna polymerase inhibitor, nucleoside analog antiviral. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for cytomegalovirus retinitis — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate
Treatments we list for cytomegalovirus retinitis
#DrugRatingPharmacy pays
170/100$56View →
2Not yet rated$56View →
3Not yet ratedView →

Full ranking · 3 treatments

Frequently asked

What treats cytomegalovirus retinitis?
Our catalog lists 3 products that may treat cytomegalovirus retinitis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is valganciclovir hydrochloride.
What is the best-rated treatment for cytomegalovirus retinitis?
By our independent recall-safety rating — not an efficacy measure — valganciclovir hydrochloride ranks highest among the products we list for cytomegalovirus retinitis. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat cytomegalovirus retinitis?
Treatments for cytomegalovirus retinitis span FDA drug classes including cytomegalovirus nucleoside analog dna polymerase inhibitor, nucleoside analog antiviral. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.